RA

Royce & Associates Portfolio holdings

AUM $12.4B Turnover 20.64%
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
Cap. Flow
-$892M
Cap. Flow %
-2.66%
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.6 years

Top Buys

Rank Stock Value
1
NUS icon
Nu Skin
NUS
+$123M
2
DAN icon
Dana Inc
DAN
+$61.6M
3
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
+$55.3M
4
CVEO icon
Civeo
CVEO
+$37.3M
5
PLUS icon
ePlus
PLUS
+$30M

Top Sells

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$107M
2
HP icon
Helmerich & Payne
HP
+$90.6M
3
OIS icon
Oil States International
OIS
+$59.7M
4
RS icon
Reliance Steel & Aluminium
RS
+$59.4M
5
MGLN
Magellan Health Services, Inc.
MGLN
+$44.4M

Sector Composition

Rank Sector Weight
1 Industrials 24.45%
2 Technology 18.1%
3 Consumer Discretionary 14.79%
4 Financials 9.92%
5 Materials 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ROST icon
1226
Ross Stores
ROST
$73.7B
$485K ﹤0.01%
14,660
-3,600
-20% -$124K
2013 Q2
4 quarters
UVE icon
1227
Universal Insurance Holdings
UVE
$1.3B
$482K ﹤0.01%
+37,200
New +$489K
2014 Q2
0 quarters
PRGS icon
1228
Progress Software
PRGS
$1.58B
$481K ﹤0.01%
+20,000
New +$436K
2014 Q2
0 quarters
XRA
1229
DELISTED
Exeter Resources Corporation
XRA
$477K ﹤0.01%
671,500
– –
2013 Q2
4 quarters
TOVX icon
1230
Theriva Biologics
TOVX
$9.63M
$475K ﹤0.01%
32
– –
2013 Q2
4 quarters
WW icon
1231
DELISTED
WW International
WW
$474K ﹤0.01%
23,500
– –
2013 Q2
4 quarters
RUTH
1232
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$474K ﹤0.01%
38,400
+7,700
+25% +$94.7K
2013 Q3
3 quarters
TRLA
1233
DELISTED
TRULIA INC (DEL)
TRLA
$474K ﹤0.01%
10,000
– –
2013 Q2
4 quarters
EXXI
1234
DELISTED
ENERGY XXI LTD COM SHS
EXXI
$468K ﹤0.01%
19,800
-10,800
-35% -$243K
2013 Q2
4 quarters
SFG
1235
DELISTED
STANCORP FINL GRP
SFG
$461K ﹤0.01%
7,200
-1,600
-18% -$99.4K
2013 Q2
4 quarters
AEL icon
1236
DELISTED
American Equity Investment Life Holding Company
AEL
$448K ﹤0.01%
18,200
+11,600
+176% +$268K
2013 Q4
2 quarters
ENSG icon
1237
The Ensign Group
ENSG
$10.2B
$439K ﹤0.01%
30,178
-41,206
-58% -$492K
2013 Q2
4 quarters
VCRA
1238
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$437K ﹤0.01%
33,100
– –
2014 Q1
1 quarter
CCBG icon
1239
Capital City Bank Group
CCBG
$833M
$433K ﹤0.01%
29,822
– –
2014 Q1
1 quarter
WSM icon
1240
Williams-Sonoma
WSM
$28.6B
$431K ﹤0.01%
12,000
+3,000
+33% +$98.6K
2013 Q2
4 quarters
CBZ icon
1241
CBIZ
CBZ
$3.01B
$424K ﹤0.01%
47,000
– –
2013 Q2
4 quarters
COO icon
1242
Cooper Companies
COO
$10.4B
$420K ﹤0.01%
12,400
-2,800
-18% -$92.5K
2013 Q3
3 quarters
TDAY icon
1243
USA Today Co
TDAY
$1.05B
$411K ﹤0.01%
29,100
+19,600
+206% +$279K
2014 Q1
1 quarter
CCXI icon
1244
DELISTED
ChemoCentryx, Inc.
CCXI
$410K ﹤0.01%
70,000
– –
2013 Q4
2 quarters
PCTI
1245
DELISTED
PCTEL, Inc. Common Stock
PCTI
$408K ﹤0.01%
50,400
+6,300
+14% +$49.7K
2013 Q2
4 quarters
OESX icon
1246
Orion Energy Systems
OESX
$100M
$407K ﹤0.01%
10,000
– –
2013 Q2
4 quarters
PST icon
1247
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$11.3M
$405K ﹤0.01%
15,000
– –
2013 Q4
2 quarters
NOA icon
1248
North American Construction
NOA
$315M
$402K ﹤0.01%
50,000
– –
2013 Q2
4 quarters
MSCI icon
1249
MSCI
MSCI
$40.7B
$399K ﹤0.01%
8,700
+5,900
+211% +$254K
2013 Q2
4 quarters
HURN icon
1250
Huron Consulting
HURN
$2.79B
$398K ﹤0.01%
5,616
– –
2013 Q2
4 quarters
48 49
50
51 52

Similar funds

JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
LC
Loews Corp New York $12.5B AUM 4.69% 1-Year Est. Return
AIM
Adapt Investment Managers Geneva, Switzerland $12.6B AUM 11.86% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Royce & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
  • Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
  • Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
  • Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
  • Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
  • Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.

Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.